Home Merck Presents New Pharmacokinetic Data on ISENTRESS (raltegravir) at 14th European AIDS Conference
 

Keywords :   


Merck Presents New Pharmacokinetic Data on ISENTRESS (raltegravir) at 14th European AIDS Conference

2013-10-16 14:30:00| Merck.com - Product News

Dateline City: WHITEHOUSE STATION, N.J. Company Confirms Development Program for Investigational Once Daily (QD) Dosing Regimen of ISENTRESS WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, is presenting pharmacokinetic data this week on investigational formulations of a once daily (QD) dose of ISENTRESS at the 14th European AIDS Conference (EACS), sponsored by the European AIDS Clinical Society. The meeting is currently taking place in Brussels, Belgium, Oct. 16-19, 2013. The poster presentation A Single Dose Food Effect Study of Raltegravir Formulations (Poster #PE10/17) will be presented Thursday, Oct. Language: English Contact: MerckMedia Contacts:Pam Eisele, 908-423-5042Sarra Herzog, 908-423-6154orInvestor Contacts:Carol Ferguson, 908-423-4465Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: data conference european aids

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
06.11Hurricane Rafael Update Statement
06.11Summary for Hurricane Rafael (AT3/AL182024)
06.11Warning millions will struggle to pay water bill rises
06.11Atlantic Tropical Weather Outlook
06.11Tropical Storm Rafael Graphics
06.11Tropical Storm Rafael Public Advisory Number 9A
06.11Summary for Tropical Storm Rafael (AT3/AL182024)
06.11Eastern North Pacific Tropical Weather Outlook
More »